OK‐432 Therapy for Cervical Lymphangioma

Objective: To describe our experience with sclerosing treatment of lymphangiomas in the head and neck region by intralesional injections of OK‐432.

[1]  M. Höllwarth,et al.  OK-432 therapy of lymphangiomas in children , 1996, European Journal of Pediatrics.

[2]  Kuender D Yang,et al.  Effect of picibanil (OK432) on neutrophil-mediated antitumor activity: Implication of monocyte-derived neutrophil-activating factors , 2005, Cancer Immunology, Immunotherapy.

[3]  A. Pierro,et al.  Is intralesional injection of OK-432 effective in the treatment of lymphangioma in children? , 2003, Surgery.

[4]  T. Kennedy,et al.  Cystic Hygroma/Lymphangioma: A Rational Approach to Management , 2001, The Laryngoscope.

[5]  M. Sung,et al.  Sclerotherapy With Picibanil (OK‐432) for Congenital Lymphatic Malformation in the Head and Neck , 2001, The Laryngoscope.

[6]  K. Orita,et al.  The prognostic advantage of preoperative intratumoral injection of OK-432 for gastric cancer patients , 2001, British Journal of Cancer.

[7]  J. P. Pracy,et al.  Treatment of lymphangiomas of the head and neck in children by intralesional injection of OK-432 (Picibanil). , 2000, Clinical otolaryngology and allied sciences.

[8]  C. Luzzatto,et al.  Sclerosing treatment of lymphangiomas with OK-432 , 2000, Archives of disease in childhood.

[9]  N. Bauman,et al.  Treatment of Lymphangiomas in Children: An Update of Picibanil (OK-432) Sclerotherapy , 1999, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[10]  T. Morisaki,et al.  The past, the present and future of the OK-432 therapy for patients with malignant effusions. , 1998, Anticancer research.

[11]  A. Nagashima,et al.  A Syndrome of Inappropriate Secretion of Antidiuretic Hormone Associated with Pleuritis Caused by OK-432 , 1998, Respiration.

[12]  Y. Sato,et al.  OK-432 therapy for lymphangiomas. , 1996, Archives of otolaryngology--head & neck surgery.

[13]  E. Deguchi,et al.  OK-432 therapy for lymphangioma in children: why and how does it work? , 1996, Journal of pediatric surgery.

[14]  E. vanSonnenberg,et al.  Percutaneous sclerotherapy of lymphangiomas. , 1995, Radiology.

[15]  E. Deguchi,et al.  OK-432 therapy in 64 patients with lymphangioma. , 1994, Journal of pediatric surgery.

[16]  Toshio Takahashi,et al.  Intracystic injection of OK‐432: A new sclerosing therapy for cystic hygroma in children , 1987, The British journal of surgery.